by John A. Jenkins | Sep 11, 2024 | FDA, FOIA, FTC, SEC
FOIAengine Explores the Widespread Use of “Neither Confirm Nor Deny” By John A. Jenkins We’re taking a look this week at a frequently used Freedom of Information Act exemption that isn’t mentioned anywhere in the statutory language. It’s known as “Glomar” among the...
by John A. Jenkins | Sep 4, 2024 | FOIA, Politics, SEC
FOIAengine: DNC’s Five Requests Also Target Nominee’s Venture Capital Partners Caroline Graham is the Democratic National Committee’s research director, a $144,000-a-year job that puts her on the front line of gathering dirt on the Republican vice-presidential...
by John A. Jenkins | Aug 14, 2024 | FOIA, Litigation, News Media, SEC, Short-Selling
FOIAengine: How the “Bounty Hunter of Wall Street” Hedged His Bets As a young man, Andrew Left was a “real serious kid” – and very religious. He wanted to be a rabbi. But then, in his telling, Left saw a newspaper ad that said, “Earn $100,000.” “I thought, ‘Yeah,...
by John A. Jenkins | Jul 17, 2024 | FOIA, Law Firms, SEC, Stock Market
The American Securities Association Uses a FOIA Lawsuit to Advance Its Agenda Two months ago, the two Republican members of the Securities and Exchange Commission blasted their own agency for what they called a meritless prosecution of stock exchanges. In a blunt...
by John A. Jenkins | Jul 10, 2024 | FOIA, Hedge Funds, Litigation, SEC
FOIA Requests Reveal Perils and Possibilities of the Consolidated Audit Trail, aka “Mass Surveillance” Imagine a time when anyone might be able to file a Freedom of Information Act request with the Securities and Exchange Commission for a complete audit-trail report...
by Randy E. Miller | Jun 27, 2024 | FDA, FOIA, SEC
FOIAengine Reveals Trends Behind the Big Numbers at FDA, SEC This week we analyze the sources of Freedom of Information Act requests made during May to the Food and Drug Administration and the Securities and Exchange Commission. This analysis provides a macro view...
